Name-Brand Medications Driving Spike in U.S. Drug Spending
Greatest costs for Humira, Remicade, Enbrel, Novolog, and Neulasta
Heart Disease Leading Cause of Death in Low-Income Counties
Greatest shift to cancer as leading cause of death seen in highest-income counties in United States
Sudden Cardiac Death Rates Up in Blacks Versus Whites
Risk still up after adjustment for sociodemographics, comorbidity, behavioral measures of health
Changes in Risk Indicators of MetS Severity Tied to T2DM Risk
For patients with prediabetes, changes in risk indicators during intervention tied to T2DM, CVD risk
AHA: Guidelines Stress Healthy Lifestyle for Lowering Cholesterol
LDL-C should be reduced with high-intensity or maximally tolerated statin therapy
AMA to Collect Data on Suicide Among Doctors-in-Training
Administration hopes to identify the systemic factors that contribute to this problem
AHA: Dapagliflozin Noninferior to Placebo for MACE in T2DM
Treatment resulted in lower HF hospitalization rate in patients with, without atherosclerosis
AHA: Limited Benefit for n-3 Fatty Acids in CVD, Cancer Prevention
Second study shows no significant results for vitamin D supplementation versus placebo
AHA: Physical Activity Guidelines for Americans Updated
Guidelines provide information on types, amounts of exercise for different population groups
AHA: Cardiogenic Shock Ups Mortality in Takotsubo Syndrome
Patients with cardiogenic shock have increased mortality in hospital, at 60 days and five years
